fluconazole
fluconazole: sourced relationships with 1 company · 7 clinical trials tracked · 1 FDA decision.
fluconazole evidence translation
What we can confirm
1 FDA record · 7 tracked trials
What it means
What to watch
Prepared research question
How could fluconazole → ANIP affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 3 study sponsors
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| ANI PHARMACEUTICALS INC (ANIP) Reported 2011-03-07 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (7)
The Drug-Drug Interaction Study of Clifutinib
Primary endpoint: Cmax
A Phase 1, Open-Label, Fixed-Sequence Study to Investigate the Effect of Fluconazole on the Pharmacokinetics of Olomorasib (LY3537982) in Healthy Participants
Primary endpoint: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of Olomorasib
A Phase 1 Crossover Design Study to Assess the Effect of CYP3A Moderate and Strong Inhibitors (Fluconazole and Itraconazole) and Strong Inducer (Carbamazepine) on the Single-dose Pharmacokinetics of ASP3082 in Healthy Adults
Primary endpoint: Pharmacokinetics (PK) of ASP3082 in plasma: Maximum Concentration (Cmax) in ASP3082
A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD, CROSSOVER STUDY IN HEALTHY PARTICIPANTS TO INVESTIGATE THE EFFECT OF FLUCONAZOLE ON PF-07248144 PHARMACOKINETICS
Primary endpoint: Area Under the Curve From Time Zero to Extrapolated Infinite Time (AUCinf) of PF-07248144 - Period 1
A Non-Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine, and Fluconazole on the Pharmacokinetics and Safety of EDP-323 in Healthy Participants
Primary endpoint: Cmax of EDP-323 with and without coadministration with Itraconazole
A Phase 1, Single-Center, Open-Label, 3-Cohort, Fixed-Sequence, Drug-Drug Interaction Study To Assess The Pharmacokinetics Of LY4100511 (DC-853) When Orally Administered Alone, When Coadministered With Itraconazole, Fluconazole, Or Carbamazepine In Healthy Adult Participants
Primary endpoint: Pharmacokinetics (PK): Maximum Observed Concentration (Cmax) of LY4100511 (DC-853)
A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin Followed by Oral Ibrexafungerp Versus Intravenous Echinocandin Followed by Oral Fluconazole (MARIO)
Primary endpoint: All-cause Mortality
Frequently asked questions
Which companies have sourced relationships with fluconazole?
fluconazole has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC.
How many clinical trials involve fluconazole?
BioSniper tracks 7 clinical trials involving fluconazole.
What is fluconazole's latest FDA decision?
The most recent tracked FDA decision for fluconazole is Approval, dated March 7, 2011.